Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02210286 · ClinicalTrials.gov registry record · NA
Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02210286: Completed NA study, sponsored by Stanford University.
NCT02210286 is a NA study that has completed, run by Stanford University. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02210286, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of supplementing Magnesium L-Threonate in people with mild to moderate dementia. The investigators' goal is to understand whether Magnesium L-Threonate will be associated with improvement in memory and brain function.
Interventions
- DIETARY_SUPPLEMENT Magtein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02210286
The ClinicalTrials.gov registry entry for NCT02210286 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magtein is the first listed.
NCT02210286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02210286 about?
NCT02210286 is a clinical study titled "Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia". The purpose of this study is to examine the effects of supplementing Magnesium L-Threonate in people with mild to moderate dementia. The investigators' goal is to understand whether Magnesium L-Threonate will be associated with improvement in memory and brain function.
What is the current status of trial NCT02210286?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2014-07. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02210286?
The interventions under investigation include: Magtein (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02210286?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.